Skip to main content
. 2011 Apr 19;2011:406473. doi: 10.1155/2011/406473

Table 2.

Drug development using WHHL/WHHLMI rabbits.

Lipid-lowering effect  Lipid-lowering effect
Aorta Coronary arteries
Cholesterol synthesis inhibitors
 Statins O X, O O
 Squalene synthesis inhibitor O O O
Anion exchanger O O
Statins + Anion exchanger O O O
MTP inhibitor O
ACAT inhibitor X, O X, O X, O
Antioxidants
 Probucol O O
 Vitamin E X X, O
Colony stimulating factor
 MCSF X, O O
 GMCSF X, O O
Apo E X, O O
Fibrate X
Fish oils, ommega-3 fatty acids X, O X, O
Thiazolidinedione X Δ Δ
Thiazolidinedione + statin O O O
Antihypertensive
 ACE inhibitor X O
 AT-II receptor antagonists X O
 Calcium antagonists X X
 Beta-blockers X X
Gene therapy O

O: effective; Δ: partly effective; X: no effect.

Modified from Shiomi and Ito [8].